Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association

One of 5 people will develop heart failure over his or her lifetime. Early diagnosis and better understanding of the pathophysiology of this disease are critical to optimal treatment. The "omics"-genomics, pharmacogenomics, epigenomics, proteomics, metabolomics, and microbiomics- of heart...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation. Genomic and precision medicine 2019-10, Vol.12 (10), p.458
Hauptverfasser:	Cresci, Sharon, Pereira, Naveen L, Ahmad, Ferhaan, Byku, Mirnela, de las Fuentes, Lisa, Lanfear, David E, Reilly, Carolyn M, Owens, Anjali T, Wolf, Matthew J
Format:	Artikel
Sprache:	eng
Schlagworte:	American Heart Association Epigenomics Heart Failure - genetics Heart Failure - metabolism Heart Failure - microbiology Heart Failure - therapy Humans Metabolomics Microbiota Precision Medicine - trends Proteomics United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!